1. Home
  2. SVRA vs THRY Comparison

SVRA vs THRY Comparison

Compare SVRA & THRY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SVRA
  • THRY
  • Stock Information
  • Founded
  • SVRA 2007
  • THRY 2012
  • Country
  • SVRA United States
  • THRY United States
  • Employees
  • SVRA N/A
  • THRY 3016
  • Industry
  • SVRA Biotechnology: Pharmaceutical Preparations
  • THRY Industrial Machinery/Components
  • Sector
  • SVRA Health Care
  • THRY Industrials
  • Exchange
  • SVRA Nasdaq
  • THRY Nasdaq
  • Market Cap
  • SVRA 527.2M
  • THRY 272.8M
  • IPO Year
  • SVRA N/A
  • THRY 2020
  • Fundamental
  • Price
  • SVRA $3.95
  • THRY $6.21
  • Analyst Decision
  • SVRA Buy
  • THRY Buy
  • Analyst Count
  • SVRA 8
  • THRY 5
  • Target Price
  • SVRA $6.88
  • THRY $15.50
  • AVG Volume (30 Days)
  • SVRA 1.7M
  • THRY 938.3K
  • Earning Date
  • SVRA 11-13-2025
  • THRY 10-30-2025
  • Dividend Yield
  • SVRA N/A
  • THRY N/A
  • EPS Growth
  • SVRA N/A
  • THRY N/A
  • EPS
  • SVRA N/A
  • THRY 0.40
  • Revenue
  • SVRA N/A
  • THRY $779,992,000.00
  • Revenue This Year
  • SVRA N/A
  • THRY N/A
  • Revenue Next Year
  • SVRA N/A
  • THRY N/A
  • P/E Ratio
  • SVRA N/A
  • THRY $15.53
  • Revenue Growth
  • SVRA N/A
  • THRY N/A
  • 52 Week Low
  • SVRA $1.89
  • THRY $6.21
  • 52 Week High
  • SVRA $4.51
  • THRY $20.92
  • Technical
  • Relative Strength Index (RSI)
  • SVRA 50.44
  • THRY 21.40
  • Support Level
  • SVRA $4.14
  • THRY $6.36
  • Resistance Level
  • SVRA $4.51
  • THRY $7.41
  • Average True Range (ATR)
  • SVRA 0.22
  • THRY 0.67
  • MACD
  • SVRA -0.05
  • THRY -0.51
  • Stochastic Oscillator
  • SVRA 11.63
  • THRY 0.55

About SVRA Savara Inc.

Savara Inc is a biopharmaceutical company. It is focused on rare respiratory diseases. The company's program, molgramostim nebulizer solution (molgramostim), is an inhaled granulocyte-macrophage colony-stimulating factor in Phase 3 development for autoimmune pulmonary alveolar proteinosis (aPAP). It has one segment specialty pharmaceuticals within the respiratory system.

About THRY Thryv Holdings Inc.

Thryv Holdings Inc is dedicated to supporting local, independent service-based businesses and emerging franchises by providing a cloud-based software platform, and marketing solutions to entrepreneurs. Its company is built upon a rich legacy in the marketing and advertising industry. The group are provider of SaaS all-in-one small business management software in addition to providing print and digital marketing solutions to SMBs. Its solutions enable SMB clients to attract and generate new business leads, manage their customer relationships efficiently with artificial intelligence (AI) tools and automation, and run their day-to-day operations to save time, compete and win in today's SMB environment. The group has two business segments; Thryv SaaS and Thryv Marketing Services.

Share on Social Networks: